Clinical Trials · NCT06926842

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Name: Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Petrelintide

Phase: Phase 2
Recruitment status: Completed
Sponsor: Zealand Pharma
Enrollment: 221
Start date: Apr 2025
Locations: 48 sites, United States
Primary endpoint: Percentage Change in Body Weight

View Petrelintide compound reference